<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02245256</url>
  </required_header>
  <id_info>
    <org_study_id>1407-114-596</org_study_id>
    <nct_id>NCT02245256</nct_id>
  </id_info>
  <brief_title>Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patients</brief_title>
  <official_title>Perioperative Low-dose Dexmedetomidine Decreases Incidence of Delirium in Liver Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospira, now a wholly owned subsidiary of Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the effect of low-dose dexmedetomidine for lowering the incidence of postoperative
      delirium in liver transplant patients in the ICU.

      Single center prospective randomized placebo controlled clinical trial 0.1mcg/kg/hr of
      dexmedetomidine or equivalent amount of saline infusion started after induction of anesthesia
      for liver transplantation and continued until 48 hours after surgery.

      Outcomes will be assessed up to 1 week or transfer to ward, whichever comes first.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2014</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analysis of the incidence of postoperative delirium in liver transplant patients in the ICU.</measure>
    <time_frame>1 week or transfer to ward, whichever comes first.</time_frame>
    <description>after August 25, 2014</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analysis of the duration of postoperative delirium, ICU length of stay in liver transplant patients in the ICU.</measure>
    <time_frame>1 week or transfer to ward, whichever comes first.</time_frame>
    <description>after August 26, 2014</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>same infusion rate as experimental group (dexmedetomidine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.1mcg/kg/hr of dexmedetomidine infusion started after induction of anesthesia for liver transplantation and continued until 48 hours after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Precedex</intervention_name>
    <description>infusion of 0.1mcg/kg/hr of precedex</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo control</intervention_name>
    <description>placebo</description>
    <arm_group_label>Normal saline</arm_group_label>
    <other_name>0.9% saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (18years old or older) undergoing living-donor or deceased-donor liver
             transplantation

        Exclusion Criteria:

          -  Pediatric patients (under 18 years) Pregnancy Patients who are unresponsive at
             baseline, who have neurologic deficits at baseline, or who are allergic to
             dexmedetomidine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hogeol Ryu, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hogeol Ryu, MD, PhD</last_name>
    <phone>02-2072-2469</phone>
    <email>hogeol@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hannah Lee, MD</last_name>
    <phone>02-2072-3538</phone>
    <email>closerthan@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Agree</state>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hogeol Ryu, MD, PhD</last_name>
      <phone>82-2-2072-2469</phone>
      <email>hogeol@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Hannah Lee, MD</last_name>
      <phone>82-2-2072-3538</phone>
      <email>closerthan@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Hogeol Ryu, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.icudelirium.org</url>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2014</study_first_submitted>
  <study_first_submitted_qc>September 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2014</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ho Geol Ryu</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <keyword>delirium</keyword>
  <keyword>incidence</keyword>
  <keyword>dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

